Arcellx (ACLX) Share-based Compensation (2021 - 2025)

Arcellx's (ACLX) quarterly Share-based Compensation came in at $39.5 million in Q4 2025, down 35.39% year-on-year from $61.1 million in Q4 2024, and up 1237.11% quarter-over-quarter from -$3.5 million in Q3 2025.

Arcellx (ACLX) Share-based Compensation (2021 - 2025) Analysis & Trends

Arcellx's Share-based Compensation history runs 5 years deep, the most recent figure standing at $39.5 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 35.39% year-over-year to $39.5 million in Q4 2025; TTM through Dec 2025 was $77.9 million, a 27.51% increase from a year earlier, with the FY2025 full-year figure at $94.0 million, up 53.88% from the prior year.
  • Share-based Compensation climbed to $39.5 million in Q4 2025 per ACLX's latest filing, from -$3.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $61.1 million in Q4 2024 and bottomed at -$31.2 million in Q4 2023.
  • The 5-year median for Share-based Compensation is $5.9 million (2022), against an average of $8.4 million.
  • Across the five-year window, Share-based Compensation soared 460.12% in 2022 and plunged 638.41% in 2023, its largest moves.
  • Year by year, Share-based Compensation stood at $2.9 million in 2021, then jumped by 99.52% to $5.8 million in 2022, then plunged by 638.41% to -$31.2 million in 2023, then surged by 295.95% to $61.1 million in 2024, then plunged by 35.39% to $39.5 million in 2025.
  • Per Business Quant, the three latest ACLX Share-based Compensation figures stand at $39.5 million (Q4 2025), -$3.5 million (Q3 2025), and $18.1 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 39.47 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 39.47 Mn
Dec 31, 2025 39.47 Mn
Sep 30, 2025 -3.47 Mn
Sep 30, 2025 -3.47 Mn
Jun 30, 2025 18.08 Mn
Jun 30, 2025 18.08 Mn
Mar 31, 2025 23.82 Mn
Mar 31, 2025 23.82 Mn
Dec 31, 2024 61.09 Mn
Dec 31, 2024 61.09 Mn
Sep 30, 2024 -29.98 Mn
Sep 30, 2024 -29.98 Mn
Jun 30, 2024 15.14 Mn
Jun 30, 2024 15.14 Mn
Mar 31, 2024 14.85 Mn
Mar 31, 2024 14.85 Mn
Dec 31, 2023 -31.17 Mn
Dec 31, 2023 -31.17 Mn
Sep 30, 2023 10.61 Mn
Sep 30, 2023 10.61 Mn